Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q3 2019 · 10-Q
Revenue$241.41M$241.41M−10.8% vs Q3 2018 Net Income$38.17M$38.17M−87.9% vs Q3 2018 EPS Diluted$0.73$0.73−87.6% vs Q3 2018 Gross Profit$139,235,000−5.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$43,330,000−8.1% Free Cash Flowderived$41,265,000−2.4% Margins · derivedGross margin57.7%+3.1 pt vs Q3 2018
Operating margin32.1%+1.3 pt vs Q3 2018
Net margin15.8%−100.5 pt vs Q3 2018
ended Dec 31, 2018 · filed Feb 7, 2019 · 38 d after period end